SHANGHAI GENOMICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C07K PEPTIDES 1135
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8765726 Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiationDec 17, 07Jul 01, 14[A61K, A01N]
8084465 Derivatives of pryidone and use thereofSep 17, 10Dec 27, 11[A61K, A01N]
8022087 Derivatives of pyridone and use thereofSep 17, 10Sep 20, 11[A61K, A01N]
7825133 Derivatives of pyridone and the use of themNov 14, 03Nov 02, 10[A61K, A01N]
7485621 Tumor tag and the use thereofSep 09, 02Feb 03, 09[A61K, C07H, C12P, C12N, G01N, C07K]
7462704 Tumor marker and its useFeb 27, 03Dec 09, 08[C07H]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0249,347 USE OF PYRIDONE DERIVATIVES IN THE PREVENTION OR TREATMENT OF TISSUE OR ORGAN TOXICITY INDUCED BY CYTOTOXIC AGENTS AND RADIATIONAbandonedMay 12, 14Sep 04, 14[A61K, A61N]
2008/0037,124 Optical Member And Manufacturing Method ThereofAbandonedMar 31, 05Feb 14, 08[G02B]
2007/0020,269 Phosphokinase and the usage thereofAbandonedJun 28, 06Jan 25, 07[A61K, C07H, C12P, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.